MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$3,781K
Net Income
-$72,936K
Net Profit Margin
-1929.01%
EPS
-$1.04
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Collaboration and license revenue
3,781
3,047
85,090
90
Research and development
68,282
64,980
57,608
49,438
General and administrative
12,524
11,687
12,767
11,837
Total operating expenses
80,806
76,667
70,375
61,275
Gain from operations
-77,025
-73,620
14,715
-61,185
Interest income
4,255
4,864
4,704
4,330
Other income (expense), net
-166
-4
-22
-21
Total other income, net
4,089
4,860
4,682
4,309
Net gain
-72,936
-68,760
19,397
-56,876
Basic EPS
-1.04
-1.01
0.303
-1.01
Diluted EPS
-1.04
-1.01
0.303
-1.01
Basic Average Shares
70,272,018
68,064,586
63,923,252
56,126,330
Diluted Average Shares
70,272,018
68,064,586
63,923,252
56,126,330
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$4,255K
(-12.43%↓ Y/Y)
Net gain
-$72,936K
(-33.44%↓ Y/Y)
Total other income,
net
$4,089K
(-14.78%↓ Y/Y)
Other income
(expense), net
-$166K
(-172.13%↓ Y/Y)
Gain from operations
-$77,025K
(-29.55%↓ Y/Y)
Collaboration and license
revenue
$3,781K
(25106.67%↑ Y/Y)
Total operating
expenses
$80,806K
(35.87%↑ Y/Y)
Research and development
$68,282K
(42.40%↑ Y/Y)
General and
administrative
$12,524K
(8.72%↑ Y/Y)
Buy us a coffee
4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc. (FDMT)